Revanex and Zydenar awarded for New Drug Development Prize.
[First APA new drug: Revanex]
Revanex developed by Yuhan is the first APA drug, a gastric acid pump antagonist, in the world,...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
